Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway

Biochimica et Biophysica Acta - Molecular Basis of Disease · Published 2026-07-11 · DOI 10.1016/j.bbadis.2026.168363

Authors (10)

Lu Li, Zeyu Wang, Yinglan Ji, Raorao Wang, Xiangjuan Qi, Yana Zhu, Yaping Wang, Xiaoyang Zhang, Man Li, Yong Jiang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, L., Wang, Z., Ji, Y., et al. (2026). Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway. Biochimica et Biophysica Acta - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168363

Related articles